[ad_1]
New anti-cancer drug increases survival rates by 30% New Straits Times
CHICAGO: A new form of medication dramatically improves the survival rate of younger women with the most common type of bad cancer, researchers said Saturday, citing the results of an international clinical trial. The findings, presented at the annual meeting of the American Society of Clinical Oncology in Chicago, showed that the addition of ribociclib, a cell cycle inhibitor, increased the survival rate to 70% after three years and half. The mortality rate was 29% lower than that observed when patients, all under the age of 59 and pre-menopausal, were randomly badigned to placebo. Lead author Sara Hurvitz at …
View full coverage on Google News
[ad_2]
Source link
